FDA’s Diversity in Clinical Trials Plan: Why It Fails to Address Key Barriers for Underrepresented Communities
This is an AI-Generated podcast. This podcast discusses the FDA’s recent guidance on inclusion and diversity in clinical trials...
This is an AI-Generated podcast. This podcast discusses the FDA’s recent guidance on inclusion and diversity in clinical trials...
This is an AI-Generated podcast. The pharmaceutical industry, often viewed as a pillar of global innovation, is facing a...